Efficacy and safety of trimethoprim-sulfamethoxazole for the prevention of pneumocystis pneumonia in human immunodeficiency virus-negative immunodeficient patients: A systematic review and meta-analysis

BACKGROUND: Pneumocystis pneumonia (PCP) has a significant impact on the mortality of immunocompromised patients. It is not known whether the prophylactic application of trimethoprim-sulfamethoxazole (TMP-SMZ) can reduce the incidence of PCP and mortality in the human immunodeficiency virus (HIV)-ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rui, Tang, Zhiyong, Liu, Fu, Yang, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993619/
https://www.ncbi.nlm.nih.gov/pubmed/33765022
http://dx.doi.org/10.1371/journal.pone.0248524

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7993619/
https://www.ncbi.nlm.nih.gov/pubmed/33765022
http://dx.doi.org/10.1371/journal.pone.0248524

Ejemplares similares